๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cisplatin and mitoguazone: An induction chemotherapy regimen in advanced head and neck cancer

โœ Scribed by Arlene A. Forastiere; David J. Perry; Gregory T. Wolf; Richard H. Wheeler; Ronald B. Natale

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
525 KB
Volume
62
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Photo-chemotherapy in advanced head and
Photo-chemotherapy in advanced head and neck cancer
โœ Jacobs, John R. ;Weaver, Arthur ;Ahmed, Khurshid ;Crissman, John ;Ensley, John F ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Wiley (John Wiley & Sons) โš– 526 KB

Induction (proto) chemotherapy consisting of 3 courses of cisplatin and 120-hour 5-fluorouracil infusion was administered to 88 patients who had locally advanced, previously untreated head and neck cancer. The majority (81%) of these patients were classified as stage IV, and 17% had second primary c

Combination chemotherapy as induction th
Combination chemotherapy as induction therapy for advanced resectable head and neck cancer
โœ Tanaphon Maipang; Matinee Maipang; Alan Geater; Chingyiam Panjapiyakul; Somchai ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 581 KB

Fifty-four previously untreated patients with locally advanced resectable squamous cell carcinoma of the head and neck (SCCHN) were enrolled into a prospective randomized controlled trial to evaluate whether induction chemotherapy improves the disease-free survival compared to the standard treatment

Induction intra-arterial cisplatin and b
Induction intra-arterial cisplatin and bleomycin in head and neck cancer
โœ Dr. Sergio Frustaci; Luigi Barzan; Giuseppe Caruso; Riccardo Ghirardo; Silva Fol ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 658 KB

Fifty-two consecutive patients, affected by large T2 (>3 cm), T3, T4, NO, or N1 previously untreated squamous cell carcinoma of the head and neck, entered this phase 1-11 study. Treatment consisted of a continuous 8-day infusion on the following daily schedule: cisplatin 25 mg and bleomycin 15 rng a